About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 13607 record(s)
Req # A-2021-000503
Adverse Drug Reaction (ADR) for ALEMTUZUMAB. Report number: E2B_03393973.Organization: Health Canada
September 2021
Req # A-2021-000548
Adverse Drug Reaction (ADR) for ROSUVASTATIN CALCIUM. Report number: E2B_03745892.Organization: Health Canada
September 2021
Req # A-2021-000563
Adverse Reaction Reports (AERs) for ALEMTUZUMAB. Report numbers: E2B_03394016, E2B_03393987, E2B_03387869, E2B_03391239, E2B_03454376, E2B_03387914, E2B_03391267, E2B_03396602, E2B_03387903, E2B_03391347, E2B_03391236, E2B_03393768, E2B_03392200,…Organization: Health Canada
September 2021
Req # A-2021-000634
Adverse Drug Reaction (ADR) for METFORMIN HYDROCHLORIDE. Report number: E2B_03420918.Organization: Health Canada
September 2021
Req # A-2021-000650
Adverse Reaction Reports (AERs) for CYCLOPHOSPHAMIDE. Report numbers: 918864, 918869, 918929.Organization: Health Canada
September 2021
Req # A-2021-000756
Health Canada’s total spending on translation services under Request for Standing Offers (RFSO), Translation Services, Requisition Reference no. 1000211711 between July 1st 2019 to June 30 2020 and between July 1st 2020 and June 30th 2021. Detailed…Organization: Health Canada
September 2021
Req # A-2021-000825
Adverse Drug Reaction (ADR) for METFORMIN HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE. Report number: E2B_03506859.Organization: Health Canada
September 2021
Req # A-2021-00799
Total number of all refugee protection proceedings presided by the Member Aurina Arnab Chatterji; -A breakdown of all the proceedings by the country of origin; -Total number of positive decisions breakdown by the country of origin; -Total number of…Organization: Immigration and Refugee Board of Canada
September 2021
Req # 2A-2021-71750
Copy of briefing note/memo F-1185535 (IT OPS) Industry Engagement for the Procurement of an Enterprise Biometric Technology Solution. Please exclude cabinet confidences that would require a consultation to confirm cabinet confidences.Organization: Immigration, Refugees and Citizenship Canada
September 2021
Req # 2A-2021-57091
Copy of briefing note/memo F-1162932 (SIP) 021-22 Settlement Funding Allocations excluding cabinet confidencesOrganization: Immigration, Refugees and Citizenship Canada
September 2021